Open access
Open access
Powered by Google Translator Translator

General Gynecology

RCT: Laser treatment not better than sham treatment on symptom severity in women with postmenopausal vaginal symptoms.

13 Oct, 2021 | 01:30h | UTC

Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial – JAMA (free for a limited period)

News release: This laser is supposed to rejuvenate vaginal tissue. But scientists say it’s no better than a placebo – University of New South Wales

Editorial: Time for a “Pause” on the Use of Vaginal Laser (free for a limited period)

Author Interview: Effect of Carbon Dioxide Laser vs Sham Therapy on Women With Postmenopausal Vaginal Symptoms

Commentary: Vagina lasering for postmenopausal women ‘may be placebo’ – The Guardian

 

Commentary on Twitter

 


Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018.

13 Oct, 2021 | 01:21h | UTC

Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018 – Nature Medicine

Invited commentary: Anemia in women — an intractable problem that requires innovative solutions – Nature Medicine

 


WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18 – In many countries, ciprofloxacin resistance was exceedingly high, and decreased susceptibility or resistance to ceftriaxone and cefixime continued to emerge.

24 Sep, 2021 | 08:53h | UTC

WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study – The Lancet Microbe

 


RCT: Tamsulosin may prevent postoperative urinary retention following female pelvic reconstructive surgery.

17 Sep, 2021 | 09:56h | UTC

Tamsulosin vs placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery: a multicenter randomized controlled trial – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)

 


The USPSTF maintains the recommendation to screen for chlamydia and gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.

15 Sep, 2021 | 08:57h | UTC

Final Recommendation Statement: Screening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force

Editorial: Screening for Chlamydia and Gonorrhea – JAMA

Evidence Report : Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Author Interview: USPSTF Recommendation: Screening for Chlamydia and Gonorrhea

JAMA Patient Page: Screening for Chlamydia and Gonorrhea

 


Review | Recommendations and Nutritional Considerations for Female Athletes: Health and Performance.

15 Sep, 2021 | 08:49h | UTC

Recommendations and Nutritional Considerations for Female Athletes: Health and Performance – Sports Medicine

 


Guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery.

26 Aug, 2021 | 08:32h | UTC

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery – International Journal of Gynecological Cancer

Editorial: Standardizing ovarian cancer surgery and peri-operative care: a European Society of Gynecological Oncology (ESGO) consensus statement

 


Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging.

25 Aug, 2021 | 08:59h | UTC

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) – Insights into Imaging

Related:

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

2 Case Series and Guidance| Lymphadenopathy in COVID-19 Vaccine Recipients

COVID-19 vaccine-linked adenopathies could mimic breast malignancies

 


ACOG Guideline: Osteoporosis prevention, screening, and diagnosis.

22 Aug, 2021 | 23:08h | UTC

Osteoporosis Prevention, Screening, and Diagnosis: ACOG Clinical Practice Guideline No. 1 – Obstetrics & Gynecology

 


Cohort study: Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers.

20 Aug, 2021 | 08:39h | UTC

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study – American Journal of Obstetrics and Gynecology

 

Commentary on Twitter

 


RCT: Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse.

13 Aug, 2021 | 08:52h | UTC

Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)

 

Commentary on Twitter (video summary)

 


ACOG Guideline: Access to postabortion contraception.

10 Aug, 2021 | 08:57h | UTC

Access to Postabortion Contraception: ACOG Committee Opinion, Number 833 – Obstetrics & Gynecology

 


Review: Diseases and complications of the puerperium.

10 Aug, 2021 | 08:46h | UTC

Diseases and Complications of the Puerperium – Deutsches Ärzteblatt International

 


ASCO Resource-Stratified Guideline: Assessment of adult women with ovarian masses and treatment of epithelial ovarian cancer.

8 Aug, 2021 | 23:38h | UTC

Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline – JCO Global Oncology

Commentary: ASCO Publishes Resource-Stratified Guideline on Assessment and Treatment of Ovarian Cancer – The ASCO Post

 


Mammographic features are associated with cardiometabolic disease risk and mortality.

6 Aug, 2021 | 09:04h | UTC

Mammographic features are associated with cardiometabolic disease risk and mortality – European Heart Journal

 


RCT: Effect of an active vs. expectant management strategy on successful resolution of pregnancy among patients with a persisting pregnancy of unknown location.

4 Aug, 2021 | 09:00h | UTC

Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial – JAMA (free for a limited period)

Commentary: Active Management More Effective for Pregnancy of Unknown Location – MedPage Today (free registration required)

 


CDC releases new guidelines for the treatment of sexually transmitted infections.

23 Jul, 2021 | 10:41h | UTC

Table of Contents: Sexually Transmitted Infections Treatment Guidelines, 2021

Guideline: Sexually Transmitted Infections Treatment Guidelines, 2021 – Centers for Disease Control and Prevention

Related (just released): WHO Guidelines for the management of symptomatic sexually transmitted infections.

 

Commentary on Twitter (thread – click for more)

 


WHO Guidelines for the management of symptomatic sexually transmitted infections.

22 Jul, 2021 | 10:54h | UTC

Guidelines for the management of symptomatic sexually transmitted infections – World Health Organization

News release: Launch WHO guidelines for the management of symptomatic sexually transmitted infection – World Health Organization

 

Commentary on Twitter

 


Review: Diagnosis, evaluation, and treatment of adenomyosis.

14 Jul, 2021 | 11:01h | UTC

Diagnosis, Evaluation, and Treatment of Adenomyosis – JAMA (free for a limited period)

 


Podcast | Heavy menstrual bleeding, anticoagulation & coagulopathy in menstruating patients.

9 Jul, 2021 | 09:56h | UTC

#280 Heavy Menstrual Bleeding, Anticoagulation & Coagulopathy in Menstruating Patients – The Curbsiders

 


Clinical guidelines for female lower urinary tract symptoms.

8 Jul, 2021 | 08:44h | UTC

Clinical Guidelines for Female Lower Urinary Tract Symptoms – International Journal of Urology

 


New WHO recommendations for screening to prevent cervical cancer – the new guideline recommends an HPV DNA based test every 5 years as the preferred method, rather than visual inspection with acetic acid (VIA) or cytology (Pap smear).

7 Jul, 2021 | 08:51h | UTC

News release: New recommendations for screening and treatment to prevent cervical cancer – World Health Organization

See guidance: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


Putting people first in managing their health: new WHO guideline on self-care interventions – “Whether it’s for their experience of pregnancy and childbirth; managing fertility intentions, preventing sexually transmitted infections; enjoying better sexual health of themselves or their partner, or self-monitoring their blood pressure, access to quality self-care interventions can help meet people’s many health needs and rights”.

28 Jun, 2021 | 09:40h | UTC

News release: Putting people first in managing their health: new WHO guideline on self-care interventions – World Health Organization

See guidance: WHO consolidated guideline on self-care interventions for health

 

Commentary on Twitter (thread – click for more)

 


Guideline | Perimenopause and Postmenopause – Diagnosis and Interventions.

28 Jun, 2021 | 09:32h | UTC

Perimenopause and Postmenopause – Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020) – Geburtshilfe Frauenheilkd

 


Review: chronic pelvic pain in women.

17 Jun, 2021 | 09:36h | UTC

Chronic Pelvic Pain in Women: A Review – JAMA (free for a limited period)

Audio clinical review: Diagnosis and Clinical Care of Women With Chronic Pelvic Pain

 


Stay Updated in Your Specialty

No spam, just news.